Decoy Therapeutics(DCOY.US)

Last Updated 19:00:00 ET
longbridge loading

Decoy Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
DCOY
+8.81%
Earnings Watch·
US
DCOY
+8.81%

DCOY Q1'26 Earnings: EPS estimate is (4.12) USD

TradingView·
US
DCOY
+8.81%
TradingView·
US
DCOY
+8.81%

Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston | DCOY Stock News

StockTitan·
US
DCOY
+8.81%
StockTitan·
US
DCOY
+8.81%

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline | DCOY Stock News

StockTitan·
US
DCOY
+8.81%
StockTitan·
US
DCOY
+8.81%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
-8.81%
US
KPRX
+0.38%
US
CUPR
-1.47%
benzinga_article·
US
PFSA
-8.81%
US
KPRX
+0.38%
US
CUPR
-1.47%

Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 | DCOY Stock News

StockTitan·
US
DCOY
+8.81%
StockTitan·
US
DCOY
+8.81%

Decoy Therapeutics Regains Nasdaq Compliance After Reverse Split

Tip Ranks·
US
DCOY
+8.81%
Tip Ranks·
US
DCOY
+8.81%
© 2026 Longbridge｜Disclaimer